MIRA Pharmaceuticals, Inc.
MIRA
$0.78
$0.000.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -22.19% | -89.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.77% | -81.06% | |||
| Operating Income | -4.77% | 81.06% | |||
| Income Before Tax | -5.07% | 80.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.07% | 80.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.07% | 80.78% | |||
| EBIT | -4.77% | 81.06% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -5.11% | 81.31% | |||
| Normalized Basic EPS | -5.26% | 80.66% | |||
| EPS Diluted | -5.11% | 81.31% | |||
| Normalized Diluted EPS | -5.26% | 80.66% | |||
| Average Basic Shares Outstanding | 0.19% | 2.74% | |||
| Average Diluted Shares Outstanding | 0.19% | 2.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||